Senator Joe Manchin Calls For Government Ban Of Painkiller Zohydro

Earlier nowadays, Senator Joe Manchin (D-W.Va.) submitted a bill demanding that the Food and Drug Administration (FDA) rescind its approval of the painkiller Zohydro, which a increasing coalition of critics believes could turn out to be the next Oxycontin in the epidemic of prescription painkiller addiction.

The “Act to Ban Zohydro,” as Manchin referred to as his bill, delivers a 13-stage argument as to why the drug is merely as well unsafe and the FDA’s approval must be overturned.

Why Are Professionals Concerned About Zohydro?

Zohydro ER is a potent extended release formulation of hydrocodone, the opiate that’s the main ingredient in Vicodin amongst other drugs.

The difference is that Zohydro is ten times as powerful as any other hydrocodone-primarily based opiate painkiller available – critics contend that two capsules could be fatal to someone with out a higher tolerance for opiates, and a single pill could kill a child. If brought to market place, it would be the only drug that utilizes hydrocodone alone to deal with continual soreness.

Senator Joe Manchin (D.-W.Virginia) urges a ban of super potent opiate painkiller Zohydro – prior to it is brought to industry. (Photo: public domain)

Senator Joe Manchin (D.-W.Virginia) urges a ban of super potent opiate painkiller Zohydro – prior to it’s brought to market place. (Photograph: public domain)

Between Manchin and colleagues’ major factors:

• Deaths from prescription opioids have quadrupled in 10 many years from more than 4,000 in 1999 to 16, 651 in 2010.


• The FDA itself has announced that death and addiction from prescription painkillers has grow to be a national epidemic.


• Zohydro’s time-release formula could easily be altered by abusers to obtain a “heroin-like impact.”


• The FDA’s own advisory committee recommended against approval of Zohydro.


• The CDC has announced that lowering deaths from painkiller overdose and abuse is a primary objective for 2014.


• The public burdens that Zohydro would impose “outweigh its therapeutic potential” given that there are many other hydrocodone-based mostly painkillers – and other discomfort prescription drugs and ache control approaches – offered.
  
  

Two weeks in the past, I reported on the expanding movement among physicians, lawmakers, addiction professionals, and law enforcement specialists calling themselves Fed Up to flip close to the FDA’s approval procedure primarily based on Zohydro’s prospective for abuse and addiction. In what I termed a Just Say No to Zohydro campaign, more than forty specialists wrote a letter to FDA Commissioner Margaret Hamburg arguing that the FDA was mistaken in approving Zohydro ER,  the growing epidemic of painkiller addiction.

My story also obtained an onslaught of comments from chronic soreness sufferers arguing that they want Zohydro, and their opinions are well worth reading as well.

In the previous two weeks, Manchin and Senator Charles Schumer (D.-New York) have named on Wellness and Human Providers chief Kathleen Sibelius in letters to overturn the FDA’s approval.

In Senate hearings nowadays, FDA Commissioner Margaret Hamburg fought back, calling Zohydro “unique” and saying the drug’s positive aspects in treating continual soreness treat ache need to outweigh fears of its prospective for abuse.

The motion to ban Zohydro is a bipartisan effort – the Fed Up letter to Hamburg was signed by three Republican senators, Mitch McConnell (R-Kentucky), Lamar Alexander (R-Tennessee), and Tom Coburn (R-Oklahoma). McConnell is Senate Minority Leader and Alexander is a ranking member on the Health Committee.

A Senate overturn of an FDA approval for Zohydro would have a variety of dramatic longterm consequences, such as setting a precedent for this kind of action. There would also be enormous consequences for Zogenix, Inc., the maker of Zohydro, which noticed its stock drop in relation to the preceding skilled protest campaigns.

Zogenix’ techniques in winning approval for Zohydro have also come below fire.

A number of weeks ago, according to blog TheHill, Manchin and Senator David Vitter (R-Louisiana) began hunting into expenses of undue influence by the pharmaceutical sector right after complaints started surfacing that sector lobbyists contributed much more than $ ten,000 to acquire meetings with the FDA to discuss Zohydro.

Just a week ago, Zogenix, Inc. announced that it would commence providing Zohydro to a limited variety of pharmacies. Shares of Zogenix closed up 4.6 % at $ 3.67.

For much more news about Zohydro and other health topics, stick to me here on Forbes.com, on Twitter, @MelanieHaiken, and subscribe to my posts on Facebook.

Senator Joe Manchin Calls For Government Ban Of Painkiller Zohydro

Can A Wisconsin Senator And A Superstar Lawyer Prevent Members Of Congress From Gaining Subsidized Health Insurance coverage Beneath Obamacare?

Sen. Ron Johnson (R., Wisc.). (Photograph credit: Gage Skidmore)

This week, Wisconsin Senator Ron Johnson (R.) filed a lawsuit aimed at stopping members of Congress, and their staffers, from getting subsidized overall health insurance by way of Obamacare’s exchanges. “Americans are justifiably outraged when members of Congress exempt themselves from the very laws they impose on every person else.” Sen. Johnson is right to be concerned about some of the legal acrobatics that the Obama administration is going by means of to guarantee that Congress will get subsidized coverage. Will the courts side with him? It is far from specific.

Obamacare is silent on the question

As a reminder, Area 1312(d)(3)(D) of the Inexpensive Care Act requires that “the only well being ideas that the Federal Government may possibly make accessible to Members of Congress and congressional staff [are these that are] produced underneath this Act…or supplied via an Exchange established underneath this Act.”

Prior to Obamacare, these individuals participated in the Federal Staff Well being Positive aspects System (FEHBP), beneath which around 3-fourths of the premium expense is subsidized by the government. But the Inexpensive Care Act is silent on the query of whether or not these subsidies can be utilized, beneath 1312(d)(3)(D), to the programs congressmen and staffers should now buy. If the strategies cannot be subsidized, it quantities to a quite substantial spend lower for staffers, specifically for people at the reduce end of the shell out scale. So numerous congressmen have quietly sought to make sure that the Obama administration agrees to reroute the outdated FEHBP subsidies by means of the exchanges.

We’ve covered the topic of this attempted congressional “exemption” extensively at The Apothecary: the background of how this provision identified its way into the law efforts by Republicans to force all federal workers to eat their personal exchange cooking Democratic complaints that the provision is unfair and the eventual ruling by the Workplace of Personnel Management that members of Congress could, in fact, reroute their FEHBP subsidies by way of the exchanges.

Paul Clement is on the situation

Johnson is joined in his lawsuit by a high-powered ally: Paul Clement, the superstar former U.S. Solicitor Standard who argued the Obamacare constitutional challenge before the Supreme Court in 2012. Rick Esenberg of the Wisconsin Institute for Law &amp Liberty is also operating with Sen. Johnson.

Clement explained he joined the situation because, in contrast to several of the other Obamacare improvisations we’ve seen this 12 months, there are lots of folks in this case with the legal standing to sue the government. “What we believe gives somebody…standing to raise an objection is that…this is not an abstract concern. This is a provision that especially impacts how Senator Johnson and his workplace get their overall health care it has an effect on how the Senator classifies employees within his office.”

The difficulty is that the provision wasn’t written plainly. It is silent on the question of no matter whether or not the government can provide congressmen subsidized coverage in the Obamacare exchanges. The Congressional Analysis Service, Congress’ in-home feel tank, looked into the legal ins and outs in 2010 and concluded that the Obama administration did have the legal authority to subsidize coverage. “It seems the segment might supply the authority for the federal government to make a contribution to the overall health insurance coverage premiums of Members of Congress and congressional personnel,” CRS wrote.

There are oddities with regards to the way in which OPM implemented this provision. The exchanges are meant for folks and small employers Congress is neither. But it is challenging to see where the provision especially prohibits the ability of the government to subsidize Congress’ well being insurance by means of the exchanges.

Republicans have to tackle Obamacare’s core issues

If the American public does not want its Congressmen to have subsidized coverage beneath Obamacare, Congress need to pass a law making that clear. Indeed, Louisiana Sen. David Vitter (R.) has launched legislation to do just that. But the Democratically-controlled Senate won’t deliver it up for a vote, and neither will the Republican-managed House.

It will be beneficial for members of Congress and their staffs to enroll onto the exchanges and see what type of health coverage tens of millions of Americans will receive on them. But I’d enjoy to see Sen. Vitter—or any person else—introduce a bill that would deal with the steep fee hikes that millions of Americans will encounter with their overall health insurance coverage premiums.

There’s a explanation why Republicans haven’t accomplished that. Creating substantial modifications to Obamacare—the variety that would carry charges downward—involve tradeoffs. Some individuals would get to pay much less for insurance whilst others would shell out a lot more. And the GOP, at least for now, has no interest in pushing expenses that aren’t supremely well-liked.

At the end of the day, if Republicans are critical about repairing our flawed and bankrupt overall health-care method, they are going to have to bite the bullet. Enabling younger folks to purchase more affordable insurance coverage, for instance, indicates that numerous old people—in the short term—would shell out far more. And previous people vote Republican.

*    *    *

Go through Avik’s new guide, How Medicaid Fails the Poor (Encounter, 2013), accessible at Amazon and other main merchants.

Comply with @Avik on Twitter, Google+, and YouTube, and The Apothecary on Facebook.

Or, signal up to receive a weekly e-mail digest of articles from The Apothecary.

*    *    *

INVESTORS’ NOTE: The biggest publicly-traded players in Obamacare’s health insurance exchanges are Aetna (NYSE:AET), Humana (NYSE:HUM), Cigna (NYSE:CI), Molina (NYSE:MOH), WellPoint (NYSE:WLP), and Centene (NYSE:CNC), in buy of the variety of uninsured exchange-eligible Americans for whom their programs are available.

Can A Wisconsin Senator And A Superstar Lawyer Prevent Members Of Congress From Gaining Subsidized Health Insurance coverage Beneath Obamacare?

Senator Feinstein"s Christmas Folly

Sen. Dianne Feinstein (Photo credit score: DonkeyHotey)

I dislike seeing politicians doing issues that are misguided, especially when they are supposed to be representing me.  Diane Feinstein, the senior senator from California, was guilty of that in a December 20 letter to President Obama, which go through in element: “It is my sturdy viewpoint that consumers have the correct to know whether or not their meals originates from genetically modified organisms.  Your administration should reevaluate the Foods &amp Drug Administration’s outdated policy that genetically engineered food does not require to disclose this reality on needed labels.”

She is so misguided.  Mandatory labeling of genetically modified, or genetically engineered (GE), meals fails every test: scientific, economic, legal and common sense.

Nevertheless, undeterred by details, advocates of the type of labeling requested by Feinstein claim that GE food items are somehow “unnatural” and may be unsafe.  And what could be wrong with letting shoppers know what’s in their meals and making it possible for them to determine what to buy?

Truly, a lot.

The terms “genetically modified” and “genetically engineered” are themselves misleading.  Such food items do not in any way constitute a meaningful “category,” which helps make any choice of what to include wholly arbitrary.  Nor are they much less protected or significantly less “natural” than 1000′s of other widespread meals.  In fact, as federal regulators have mentioned, a necessary label erroneously implies a meaningful distinction in which none exists.

Contrary to what activists would have you think, genetic modification has been with us for millennia, and there is a seamless continuum from crude, older tactics to newer, more exact ones.  A genetic modification approach in use given that the 1950s, for example, is induced-mutation breeding, which entails exposing seeds or cells to ionizing radiation or toxic chemical substances to induce random, desirable genetic mutations (but which are accompanied by innumerable, other, uncharacterized genetic changes).  Thousands of such mutation-bred crop types have been commercialized in North America and Europe and are part of our diet regime and given that the 1930′s plant breeders have carried out “wide cross” hybridizations, in which large numbers of “alien” genes are moved from one species or a single genus to yet another to generate plant varieties that can not and do not exist in nature.  Common commercial crops derived from broad crosses consist of tomato, potato, sweet potato, oat, rice, wheat, corn, and pumpkin, between other individuals.

When plant breeders use these “conventional,” older breeding technologies, they do not know the actual genetic modifications that produced the desirable traits and far more important, they have no concept what other alterations have occurred concomitantly in the plant, like those that could increase ranges of toxins or alter the ability to result in allergic reactions.  (However, unlike genetic engineering, they are subject to no government regulation at all.)  Better precision is what helps make modern genetic engineering the two a lot more versatile and safer than other strategies.

On typical, each day Americans consume dozens of varieties of fruits, greens, and grains derived from wide crosses.  And as for meals produced from plants with the contemporary molecular methods of genetic engineering – the only type that Feinstein wants labeled — Americans have previously consumed a lot more than 3 trillion servings of them with not even a single tummy ache.

The FDA does not demand labeling of food items with genetically engineered ingredients simply because such details would not be “material” (a legal phrase of art) – that is, connected to safety or appropriate usage — and would be misleading.  This technique to labeling has been upheld the two immediately and indirectly by various federal court choices that have persistently struck down necessary labeling not supported by data.

In the 1990′s, a group of Wisconsin buyers sued the FDA, arguing that the agency’s decision not to need the labeling of dairy items from cows handled with a bioengineered protein named bovine somatotropin, or bST, allowed those items to be labeled in a false and misleading method.  (In other phrases, the plaintiffs desired the identical sort of necessary labeling requested by Sen. Feinstein.)  However, because the plaintiffs failed to demonstrate any materials variation among milk from taken care of and untreated cows, the federal court agreed with the FDA, finding that “it would be misbranding to label the item as diverse, even if shoppers misperceived the merchandise as distinct.”

In an additional federal situation, a number of food associations and companies challenged a Vermont statute that essential labeling to identify milk from cows treated with a bioengineered protein referred to as bovine somatotropin. Because the state could not show that its labeling necessity was motivated by anything at all far more than satisfying buyer curiosity, the court mentioned it could not compel milk producers to include that data on solution labels: “We are aware of no case in which consumer interest alone was adequate to justify requiring a product’s producers to publish the practical equivalent of a warning about a production method that has no discernible influence on a last item. … Absent some indication that this data bears on a sensible concern for human wellness or safety or some other sufficiently considerable governmental concern, the manufacturers are not able to be compelled to disclose it,” since it would violate constitutional ensures of commercial cost-free speech. “Were consumer interest alone ample,” said the court, “there is no end to the information that states could need companies to disclose about their production methods.”

Therefore, there is no consumers’ “right to know” arbitrary info about meals and, therefore, Feinstein’s rationale for labeling evaporates.  And if the president have been to comply with her request, his action would most likely be unconstitutional.

The mystery is what could have led the generally meticulous Feinstein (who is, incidentally, the chairman of the Senate Intelligence Committee) to send such a flawed and irresponsible message to the president.  She cites as help a January 2013 New York Times survey which supposedly identified that 93% of Americans favor this kind of labeling.  But such surveys are notoriously dependent on how the concerns are worded and in what buy they are asked, and they are often crafted in a way meant to yield a particular wanted outcome.

In addition, Feinstein ought to know that actual referendum concerns in numerous states – like her own state of California in 2012 and Washington State in 2013 – that would have necessary such labeling were rejected by the voters. She has been about prolonged ample to realize that real votes cast by millions of voters trump a trumped-up survey.

Activists opposed to present day tactics of genetic engineering have produced it clear that they regard labeling as a very first stage towards getting rid of the technologies fully.  “We are going to force them to label this meals.  If we have it labeled, then we can organize individuals not to acquire it,” mentioned 1 anti-biotechnology troglodyte.  It is ironic, as a result, that Feinstein’s letter advances their method, due to the fact drought-resistant genetically engineered plants now in testing will be invaluable to California’s drought-plagued farmers, and orange trees resistant to citrus greening will be needed to save the state’s citrus business from the insect-spread bacterial disease.

How, then, can we describe Feinstein’s letter?  Poor due diligence on the problem by staffers?  A rogue staffer using Feinstein’s car-pen to sign her identify?   A misguided effort at constituent services (where the constituents were radical anti-biotechnology activists)?  Whatever the purpose, Feinstein owes her real constituents – the voters of California – an apology and a retraction of the letter.

Senator Feinstein"s Christmas Folly